Detalhe da pesquisa
1.
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy.
Breast Cancer Res Treat
; 196(1): 121-128, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36070058
2.
Quantitative Proteomics Reveals Knockdown of CD44 Promotes Proliferation and Migration in Claudin-Low MDA-MB-231 and Hs 578T Breast Cancer Cell Lines.
J Proteome Res
; 20(7): 3720-3733, 2021 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34075748
3.
Parallel Reaction Monitoring-Mass Spectrometry (PRM-MS)-Based Targeted Proteomic Surrogates for Intrinsic Subtypes in Breast Cancer: Comparative Analysis with Immunohistochemical Phenotypes.
J Proteome Res
; 19(7): 2643-2653, 2020 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755719
4.
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial.
Breast Cancer Res Treat
; 182(1): 97-105, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32418044
5.
Clinical Application of Multiple Reaction Monitoring-Mass Spectrometry to Human Epidermal Growth Factor Receptor 2 Measurements as a Potential Diagnostic Tool for Breast Cancer Therapy.
Clin Chem
; 66(10): 1339-1348, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33001186
6.
Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.
Mol Cell Proteomics
; 17(9): 1788-1802, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29950347
7.
Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I-III breast cancer patients.
Br J Cancer
; 121(3): 230-236, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292534
8.
Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients.
Breast Cancer Res Treat
; 176(2): 453-460, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028608
9.
Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
Breast Cancer Res Treat
; 175(1): 117-127, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30671767
10.
Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy.
Radiology
; 289(2): 327-334, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30152744
11.
Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy.
Eur J Nucl Med Mol Imaging
; 45(3): 328-339, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29101445
12.
Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour.
Eur Radiol
; 28(7): 2986-2995, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380033
13.
Individual class evaluation and effective teaching characteristics in integrated curricula.
BMC Med Educ
; 17(1): 252, 2017 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29233131
14.
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer.
Br J Cancer
; 114(10): 1109-16, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27115469
15.
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
Breast Cancer Res Treat
; 158(2): 233-41, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27329169
16.
Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival.
Radiology
; 281(2): 392-400, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27195438
17.
Early Stage Triple-Negative Breast Cancer: Imaging and Clinical-Pathologic Factors Associated with Recurrence.
Radiology
; 278(2): 356-64, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26230976
18.
SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Tumour Biol
; 37(4): 4743-53, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26515337
19.
New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer.
Tumour Biol
; 37(8): 11017-24, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26894602
20.
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.
BMC Cancer
; 16: 515, 2016 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27444430